Literature DB >> 19644391

Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.

Rose C Graham1, Ann Burke, Nicolas Stettler.   

Abstract

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized among overweight adolescents. Metabolic syndrome often coexists with NAFLD in adults. This study aimed to determine whether, in US adolescents, metabolic syndrome increases the odds of alanine aminotransferase (ALT)>40 U/L, a surrogate for NAFLD.
MATERIALS AND METHODS: A cross-sectional study of the association between metabolic syndrome and ALT>40 U/L was undertaken in a sample of 12- to 19-year-olds from the National Health and Nutrition Examination Survey, 1999 to 2002, representative of the US adolescent population. Subjects were excluded for incomplete data, pregnancy, steroid or hepatotoxic drug use, cholestasis or viral hepatitis, and alcohol intake. The metabolic syndrome was defined by adult criteria adapted for pediatric body size and blood pressure. The association of metabolic syndrome with ALT>40 U/L, effect modifiers, and confounders were analyzed using National Health and Nutrition Examination Survey sampling weights.
RESULTS: Of 4902 adolescents, the 1323 included were similar to the excluded ones, except for the important variable sex (55% vs 49% male, P=0.03, respectively). The metabolic syndrome was associated with ALT>40 U/L (odds ratio [OR] 16.7, confidence interval [CI] 6.2-45.1, P<0.001) with significant interaction by sex: OR 20.4 (CI 6.2-66.7, P<0.001) for males versus 3.1 (CI 0.4-25.1, P=0.3) for females. Further stratification of males suggested interaction by ethnicity: OR 5.0 (CI 1.3-19.0, P=0.02) for Hispanics versus 34.3 (CI 7.61-55.4, P<0.001) for non-Hispanics. Among Hispanic males, adjustment for body mass index z score explained the association (OR 0.6; CI 0.1-2.9, P=0.5), whereas among non-Hispanic males, the association remained after adjustment for BMIz (OR 11.1; CI 3.2-38.0, P<0.001).
CONCLUSIONS: Metabolic syndrome is strongly associated with ALT>40 U/L in US male adolescents. Body mass index z score explained this association among Hispanics, but not among non-Hispanic males. Significant sex and ethnic differences exist in the association of pediatric metabolic syndrome with elevated ALT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644391     DOI: 10.1097/MPG.0b013e31819f73b4

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  23 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Higher Serum Alanine Transaminase Levels in Male Urokinase-Type Plasminogen Activator-Transgenic Mice Are Associated With Improved Engraftment of Hepatocytes but not Liver Sinusoidal Endothelial Cells.

Authors:  Marina E Fomin; Ashley I Beyer; Jean Publicover; Kai Lu; Sonia Bakkour; Graham Simmons; Marcus O Muench
Journal:  Cell Med       Date:  2016-11-23

3.  Ethnic differences in the link between insulin resistance and elevated ALT.

Authors:  Mark D Deboer; R Constance Wiener; Barrett H Barnes; Matthew J Gurka
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

Review 4.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

5.  Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.

Authors:  Cyrelle R Fermin; Arthur M Lee; Stephanie L Filipp; Matthew J Gurka; Mark D DeBoer
Journal:  Metab Syndr Relat Disord       Date:  2017-05-18       Impact factor: 1.894

Review 6.  Pediatric non-alcoholic fatty liver disease: New insights and future directions.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  World J Hepatol       Date:  2014-04-27

7.  Liver disease among children in Hawai'i diagnosed with metabolic syndrome.

Authors:  David E St-Jules; Corilee A Watters; James Davis; Sorrell H Waxman
Journal:  Hawaii J Med Public Health       Date:  2013-05

8.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

Authors:  Jean A Welsh; Saul Karpen; Miriam B Vos
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

9.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

Authors:  Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

10.  The effect of weight loss on pediatric nonalcoholic Fatty liver disease.

Authors:  David E St-Jules; Corilee A Watters; Ken Nagamori; Jeremy King
Journal:  ISRN Gastroenterol       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.